These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8730158)

  • 1. Loss of contact sensitization evaluated by laser Doppler blood flowmetry and transepidermal water loss measurement.
    Seo KI; Eun HC
    Contact Dermatitis; 1996 Apr; 34(4):233-6. PubMed ID: 8730158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe dermographism after topical therapy with diphenylcyclopropenone for alopecia universalis.
    Skrebova N; Nameda Y; Takiwaki H; Arase S
    Contact Dermatitis; 2000 Apr; 42(4):212-5. PubMed ID: 10750852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact allergy to colophony. Clinical and experimental studies with emphasis on clinical relevance.
    Färm G
    Acta Derm Venereol Suppl (Stockh); 1998; 201():1-42. PubMed ID: 9833065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata.
    Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute, low-dose UVB radiation on the induction of contact hypersensitivity to diphenylcyclopropenone in man.
    Friedli A; Hunziker T; Finkel B; Braathen LR
    Arch Dermatol Res; 1993; 285(1-2):1-5. PubMed ID: 7682397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement.
    Laudańska H; Reduta T; Szmitkowska D
    Rocz Akad Med Bialymst; 2003; 48():123-7. PubMed ID: 14737957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin barrier function and dermal inflammation. An experimental study of transepidermal water loss after dermal tuberculin injection compared with SLS patch testing.
    De Fine Olivarius F; Agner T; Menné T
    Br J Dermatol; 1993 Nov; 129(5):554-7. PubMed ID: 8251351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata.
    Gong Y; Zhao Y; Zhang X; Qi S; Li S; Ye Y; Yang J; Caulloo S; McElwee KJ; Zhang X
    Exp Dermatol; 2020 Mar; 29(3):231-238. PubMed ID: 30047620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
    Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
    J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
    Heffler LC; Kastman AL; Jacobsson Ekman G; Scheynius A; Fransson J
    Br J Dermatol; 2002 Aug; 147(2):222-9. PubMed ID: 12174091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo nickel allergic contact dermatitis: human model for topical therapeutics.
    Zhai H; Chang YC; Singh M; Maibach HI
    Contact Dermatitis; 1999 Apr; 40(4):205-8. PubMed ID: 10208508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical characterization of skin damage and recovery after exposure to different surfactants.
    Bárány E; Lindberg M; Lodén M
    Contact Dermatitis; 1999 Feb; 40(2):98-103. PubMed ID: 10048655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases.
    Choe SJ; Lee S; Pi LQ; Keum DI; Lee CH; Kim BJ; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):515-521.e4. PubMed ID: 29108907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.